Daiichi Sankyo

Daiichi axes 170-person Indian R&D site

UPDATED: DMC suspends Daiichi’s ‘breakthrough’ PhIII Enliven trial

Daiichi pens lung cancer pact with Dana-Farber, continuing oncology deal drive